Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phreesia, Inc. Common Stock (NY:PHR)

22.64 -0.02 (-0.09%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Phreesia, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
4 Analysts Have This To Say About Phreesia
 
Via Benzinga
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
Breaking Down Phreesia: 9 Analysts Share Their Views
 
Via Benzinga
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)
 
Via Benzinga
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)
 
Via Benzinga
Phreesia Earnings Review: Q3 Summary
 
Via Benzinga
1 Small-Cap Stock with Solid Fundamentals and 2 to Ignore
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Supply Chain
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
6 Analysts Have This To Say About Phreesia
 
Via Benzinga
Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Healthcare technology company Phreesia (NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue... 
Via StockStory
A Look Ahead: Phreesia's Earnings Forecast
 
Via Benzinga
The Latest Analyst Ratings For Phreesia
 
Via Benzinga
A Glimpse Into The Expert Outlook On Phreesia Through 4 Analysts
 
Via Benzinga
Earnings Scheduled For March 12, 2025
 
Via Benzinga
Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for. 
Via StockStory
A Glimpse Into The Expert Outlook On Phreesia Through 6 Analysts
 
Via Benzinga
Assessing Phreesia: Insights From 12 Financial Analysts
 
Via Benzinga
Analyst Expectations For Phreesia's Future
 
Via Benzinga
Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst
Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised. 
Via Benzinga
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga
Earnings Scheduled For December 9, 2024
 
Via Benzinga
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
Recap: Phreesia Q4 Earnings
 
Via Benzinga
Phreesia Earnings Preview
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
 
Via Benzinga
PHR Stock Earnings: Phreesia Beats EPS, Beats Revenue for Q1 2025
PHR stock results show that Phreesia beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
PHR Stock Earnings: Phreesia Misses EPS, Beats Revenue for Q4 2024
PHR stock results show that Phreesia missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.